Multivessel vs. culprit-lesion only percutaneous coronary intervention in ST-elevation myocardial infarction

Hans-Josef Feistritzer1, Alexander Jobs2, Steffen Desch2

  • 1Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Strümpellstr. 39, 04289, Leipzig, Germany. Hans-Josef.Feistritzer@medizin.uni-leipzig.de.

Herz
|May 21, 2020
PubMed

Insights

Complete revascularization in ST-elevation myocardial infarction (STEMI) patients reduces cardiovascular death and heart attacks. This review examines evidence for optimal treatment of non-infarct arteries in STEMI care.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • The optimal management of non-infarct-related coronary arteries in ST-elevation myocardial infarction (STEMI) patients remains a long-standing debate.
  • Previous trials suggested benefits of multivessel percutaneous coronary intervention (PCI) mainly by reducing revascularization rates.

Purpose of the Study:

  • To review current evidence on revascularization strategies for patients with STEMI.
  • To evaluate the impact of complete revascularization versus culprit-lesion-only PCI.

Main Methods:

  • Systematic review of randomized controlled trials and relevant clinical studies.
  • Analysis of data from recent large-scale trials like the COMPLETE trial.

Main Results:

  • The COMPLETE trial demonstrated a significant reduction in the composite endpoint of cardiovascular mortality and myocardial infarction with complete revascularization.
  • Earlier trials indicated benefits of multivessel PCI, primarily through decreased need for repeat procedures.

Conclusions:

  • Complete revascularization appears to be a beneficial strategy in STEMI patients, reducing major adverse cardiovascular events.
  • Further evidence supports a comprehensive approach to managing all significant coronary lesions in STEMI.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
560
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
142
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
287
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
810